CEO & Director
Mr. Dhaliwal is a registered pharmacist, CEO and director of multiple publicly traded cannabis companies. He has served as a director of a licensed producer and extractor. He has extensive knowledge in agricultural, medical and pharmaceutical operations.
Mr. Dhaliwal holds a Bachelor of Pharmacy from the University of British Columbia and a Bachelor of Science in biology from the University of Victoria. Mr. Dhaliwal is a certified medical cannabis practitioner.
CFO & Director
Mr. Chaudhry is an experienced businessman who will join the board as an independent director. Mr. Chaudhry sits on a number of public company boards and specializes in executive management services, including corporate development, investor relations, financial reporting, company filings, budgeting and overseeing corporate governance, while achieving company objectives and maintaining internal cost controls.
Mr Anstey was educated at the University of Victoria’s School of Business. For the past decade, George’s entrepreneurial mind has been focused on the booming cannabis industry: contracting with commercial license holders like Broken Coast Cannabis, a medical cannabis company bought by Aphria for $230 million CAD in 2018. George now consults on compliance matters for early-stage cannabis companies, helping those organizations to navigate the license application requirements set by Health Canada. This experience in guiding new industries will be invaluable in promoting psilocybin.